Amalgamated Bank’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33K | Hold |
3,514
| – | – | ﹤0.01% | 1952 |
|
|
2025
Q1 | $25K | Buy |
3,514
+367
| +12% | +$2.61K | ﹤0.01% | 1988 |
|
|
2024
Q4 | $37K | Hold |
3,147
| – | – | ﹤0.01% | 1915 |
|
|
2024
Q3 | $65K | Hold |
3,147
| – | – | ﹤0.01% | 1780 |
|
|
2024
Q2 | $70K | Buy |
3,147
+141
| +5% | +$3.14K | ﹤0.01% | 1787 |
|
|
2024
Q1 | $83K | Sell |
3,006
-5,571
| -65% | -$154K | ﹤0.01% | 1759 |
|
|
2023
Q4 | $262K | Sell |
8,577
-735
| -8% | -$22.5K | ﹤0.01% | 1711 |
|
|
2023
Q3 | $294K | Buy |
9,312
+219
| +2% | +$6.91K | ﹤0.01% | 1638 |
|
|
2023
Q2 | $371K | Sell |
9,093
-1,688
| -16% | -$68.9K | ﹤0.01% | 1573 |
|
|
2023
Q1 | $402K | Sell |
10,781
-2,344
| -18% | -$87.4K | ﹤0.01% | 1514 |
|
|
2022
Q4 | $458K | Buy |
13,125
+1,773
| +16% | +$61.9K | ﹤0.01% | 1499 |
|
|
2022
Q3 | $635K | Buy |
11,352
+222
| +2% | +$12.4K | 0.01% | 1316 |
|
|
2022
Q2 | $576K | Sell |
11,130
-290
| -3% | -$15K | 0.01% | 1399 |
|
|
2022
Q1 | $830K | Sell |
11,420
-855
| -7% | -$62.1K | 0.01% | 1298 |
|
|
2021
Q4 | $1.45M | Buy |
12,275
+30
| +0.2% | +$3.55K | 0.01% | 1078 |
|
|
2021
Q3 | $1.64M | Buy |
12,245
+182
| +2% | +$24.4K | 0.01% | 1019 |
|
|
2021
Q2 | $1.95M | Buy |
12,063
+4,253
| +54% | +$689K | 0.02% | 967 |
|
|
2021
Q1 | $627K | Sell |
7,810
-25
| -0.3% | -$2.01K | 0.02% | 855 |
|
|
2020
Q4 | $426K | Buy |
+7,835
| New | +$426K | 0.02% | 1053 |
|